What is the appropriate assessment and management for persistent vomiting in an 18‑year‑old patient?

Assessment and Management of Persistent Vomiting in an 18-Year-Old

In an 18-year-old with persistent vomiting, you must first rule out serious organic causes through targeted history and examination, then treat empirically with antiemetics while investigating the underlying etiology—this is not chemotherapy-induced emesis, so the oncology guidelines provided are not applicable.

Initial Clinical Assessment

The priority is determining whether this represents acute (≤7 days) or chronic (≥4 weeks) vomiting, as this fundamentally changes your approach 1, 2.

Critical History Elements to Obtain

• Timing and pattern: Episodic attacks suggest cyclic vomiting syndrome (CVS); continuous suggests structural or metabolic causes
• Bilious vs non-bilious: Bilious vomiting suggests obstruction distal to the ampulla of Vater
• Relationship to meals: Immediate vomiting suggests gastric outlet obstruction; delayed suggests gastroparesis
• Associated symptoms: Headache (migraine, increased intracranial pressure), abdominal pain (obstruction, pancreatitis), neurologic symptoms (CNS pathology)
• Medication and substance use: Cannabis (cannabinoid hyperemesis syndrome), opioids, chemotherapy agents
• Psychiatric history: Anxiety, depression, eating disorders
• Pregnancy status (if applicable)

Physical Examination Red Flags

• Dehydration status (orthostatic vitals, mucous membranes, skin turgor)
• Abdominal examination for distension, tenderness, masses, surgical scars
• Neurologic examination if headache or altered mental status present
• Weight loss >5% body weight

Diagnostic Workup

Initial Laboratory Testing 2, 3

Order these immediately:

• Comprehensive metabolic panel: Electrolytes (hypokalemia, hypochloremia), glucose, renal function
• Complete blood count: Infection, anemia
• Urinalysis and urine pregnancy test (if applicable)
• Thyroid-stimulating hormone: Hyperthyroidism can cause vomiting
• Amylase/lipase: If abdominal pain present

Imaging Based on Clinical Suspicion

• Abdominal radiography: First-line if obstruction suspected (look for air-fluid levels, dilated bowel)
• CT abdomen/pelvis with contrast: If acute abdomen, obstruction not clear on plain films, or concern for malignancy
• CT head: Only if neurologic symptoms, severe headache, or altered mental status
• Upper endoscopy: If chronic symptoms with alarm features (weight loss, dysphagia, age >50) or suspected gastroparesis after negative initial workup
• Gastric emptying study: If gastroparesis suspected after endoscopy

Management Algorithm

Acute Vomiting (<7 days)

Step 1: Fluid and Electrolyte Resuscitation

• IV normal saline or lactated Ringer's for moderate-severe dehydration
• Correct electrolyte abnormalities, especially potassium and magnesium
• Monitor for metabolic alkalosis (common with persistent vomiting)

Step 2: Empiric Antiemetic Therapy

Choose based on suspected mechanism 4, 1:

First-line options:

• Ondansetron 4-8 mg IV/PO every 8 hours (5-HT3 antagonist—works on vagal afferents)
• Metoclopramide 10 mg IV/PO every 6 hours (dopamine antagonist + prokinetic—avoid if obstruction suspected)
• Promethazine 12.5-25 mg IV/PO/PR every 4-6 hours (antihistamine—sedating, useful for vestibular causes)

For refractory symptoms, add:

• Haloperidol 0.5-2 mg IV/PO every 4-6 hours (dopamine antagonist)
• Lorazepam 0.5-1 mg IV/PO/SL every 6 hours (anxiolytic, useful if anxiety component)

Critical caveat: Use scheduled dosing, not PRN—prevention is easier than treatment 5, 4.

Chronic Vomiting (≥4 weeks)

If Cyclic Vomiting Syndrome Suspected 6, 7, 8

CVS presents with stereotypical episodes of intense nausea/vomiting lasting hours to days, separated by symptom-free intervals. Strong association with migraine.

Abortive therapy for acute episodes:

• Sumatriptan 6 mg subcutaneous or 20 mg nasal spray (can use while actively vomiting)
• Ondansetron 8 mg sublingual tablet
• Promethazine 25 mg suppository (induces sedation)
• Lorazepam 1-2 mg sublingual (sedation is therapeutic goal)
• IV fluids with dextrose (essential—hypoglycemia worsens episodes)

Prophylactic therapy to prevent episodes:

• Amitriptyline 25-50 mg daily at bedtime (first-line prophylaxis) 7
• Consider adding propranolol or nebivolol if migraine-associated 7

If Gastroparesis Suspected

After confirming with gastric emptying study:

• Metoclopramide 10 mg PO 30 minutes before meals and at bedtime (mainstay of therapy) 8
• Small, frequent meals (6 per day)
• Low-fat, low-fiber diet
• Avoid medications that delay gastric emptying (opioids, anticholinergics)

If Psychogenic Vomiting Suspected 9

Diagnosis of exclusion after ruling out organic causes. Consider if:

• Vomiting occurs primarily in stressful situations
• History of psychiatric disorders (anxiety, depression, eating disorders)
• Absence of nausea between episodes
• Normal weight or weight gain despite vomiting

Management:

• Psychiatric referral for cognitive behavioral therapy
• Consider SSRI if underlying anxiety/depression
• Avoid reinforcing behavior with excessive testing

Common Pitfalls to Avoid

1. Don't assume viral gastroenteritis if vomiting persists >7 days—chronic vomiting requires investigation 1

2. Don't use metoclopramide if bowel obstruction suspected—can worsen symptoms and cause perforation

3. Don't forget to check pregnancy status—hyperemesis gravidarum requires specific management 10

4. Don't overlook medication adverse effects—review ALL medications and supplements, including cannabis use (cannabinoid hyperemesis syndrome presents with compulsive hot bathing behavior)

5. Don't use PRN antiemetics for persistent vomiting—scheduled dosing is more effective 5, 4

6. Don't delay IV fluids—dehydration and electrolyte abnormalities worsen nausea and can cause serious complications

When to Hospitalize

Admit if any of the following:

• Inability to tolerate oral fluids or medications
• Severe dehydration or electrolyte abnormalities
• Weight loss >5% body weight
• Suspected obstruction or acute abdomen
• Intractable vomiting despite outpatient management
• Concern for serious underlying pathology (CNS lesion, malignancy)

Note: The provided guidelines 5, 4, 11, 5, 11, 12, 11 focus on chemotherapy-induced nausea/vomiting and are not directly applicable to this clinical scenario. The approach outlined above is based on general medical management of persistent vomiting in young adults 6, 1, 2, 8, 3.